These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 25953938

  • 1. [The efficacy of ivabradine in chronic heart failure (review)].
    Isakadze A, Makharadze T, Gvishiani M.
    Georgian Med News; 2015 Apr; (241):44-9. PubMed ID: 25953938
    [Abstract] [Full Text] [Related]

  • 2. Advances in the management of heart failure: the role of ivabradine.
    Müller-Werdan U, Stöckl G, Werdan K.
    Vasc Health Risk Manag; 2016 Apr; 12():453-470. PubMed ID: 27895488
    [Abstract] [Full Text] [Related]

  • 3. Beta-blockers and ivabradine in chronic heart failure: from clinical trials to clinical practice.
    Di Franco A, Sarullo FM, Salerno Y, Figliozzi S, Parrinello R, Di Pasquale P, Lanza GA.
    Am J Cardiovasc Drugs; 2014 Apr; 14(2):101-10. PubMed ID: 24327100
    [Abstract] [Full Text] [Related]

  • 4. Ivabradine: Current and Future Treatment of Heart Failure.
    Thorup L, Simonsen U, Grimm D, Hedegaard ER.
    Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):89-97. PubMed ID: 28371247
    [Abstract] [Full Text] [Related]

  • 5. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease.
    DiFrancesco D, Camm JA.
    Drugs; 2004 Aug; 64(16):1757-65. PubMed ID: 15301560
    [Abstract] [Full Text] [Related]

  • 6. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.
    Müller-Werdan U, Stöckl G, Ebelt H, Nuding S, Höpfner F, Werdan K, ADDITIONS Study Investigators.
    Exp Gerontol; 2014 Nov; 59():34-41. PubMed ID: 25193811
    [Abstract] [Full Text] [Related]

  • 7. Benefits of Heart Rate Slowing With Ivabradine in Patients With Systolic Heart Failure and Coronary Artery Disease.
    Borer JS, Deedwania PC, Kim JB, Böhm M.
    Am J Cardiol; 2016 Dec 15; 118(12):1948-1953. PubMed ID: 27780557
    [Abstract] [Full Text] [Related]

  • 8. Heart rate reduction induced by the if current inhibitor ivabradine improves diastolic function and attenuates cardiac tissue hypoxia.
    Fang Y, Debunne M, Vercauteren M, Brakenhielm E, Richard V, Lallemand F, Henry JP, Mulder P, Thuillez C.
    J Cardiovasc Pharmacol; 2012 Mar 15; 59(3):260-7. PubMed ID: 22075752
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure.
    Deedwania P.
    Drugs; 2013 Sep 15; 73(14):1569-86. PubMed ID: 24065301
    [Abstract] [Full Text] [Related]

  • 15. Is There a Role for Ivabradine in the Contemporary Management of Patients with Chronic Heart Failure in Academic and Community Heart Failure Clinics in Canada?
    Roth S, Fernando C, Azeem S, Moe GW.
    Adv Ther; 2017 Jun 15; 34(6):1340-1348. PubMed ID: 28432646
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Heart rate slowing versus other pharmacological antianginal strategies.
    Diaz A, Tardif JC.
    Adv Cardiol; 2006 Jun 15; 43():65-78. PubMed ID: 16936473
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.